Drug
hydroxychloroquine placebo
hydroxychloroquine placebo is a pharmaceutical drug with 5 clinical trials. Historical success rate of 33.3%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
2(40%)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_2
1
20%
Ph phase_3
3
60%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
3(60.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(1)
Terminated(2)
Other(2)
Detailed Status
unknown2
Terminated2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
33.3%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (20.0%)
Phase 33 (60.0%)
N/A1 (20.0%)
Trials by Status
completed120%
unknown240%
terminated240%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus
NCT04344379
terminatednot_applicable
Metabolic Effects of Hydroxychloroquine
NCT02026232
terminatedphase_2
Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)
NCT04345861
unknownphase_3
A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers
NCT04377646
unknownphase_3
Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss
NCT03305263
Clinical Trials (5)
Showing 5 of 5 trials
NCT04344379Phase 3
Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus
NCT02026232Not Applicable
Metabolic Effects of Hydroxychloroquine
NCT04345861Phase 2
Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)
NCT04377646Phase 3
A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers
NCT03305263Phase 3
Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5